171-77-7 Usage
Uses
Used in Pharmaceutical Research:
Spiro[benzofuran-3(2H),4'-piperidine] is utilized as a potential drug candidate for various medical conditions due to its multifaceted pharmacological profile.
Used in Anti-inflammatory Applications:
spiroUsed in Analgesic Applications:
Spiro[benzofuran-3(2H),4'-piperidine] serves as an analgesic, aiming to alleviate pain by targeting specific mechanisms that contribute to the sensation of pain.
Used in Anticonvulsant Applications:
It is applied as an anticonvulsant, potentially helping to prevent or reduce the severity of seizures in conditions like epilepsy.
Used in Neurological Disorder Treatment:
In the treatment of neurological disorders, spiro[benzofuran-3(2H),4'-piperidine] is used as a therapeutic agent for conditions such as Alzheimer's disease and Parkinson's disease, due to its potential neuroprotective and restorative effects.
Used in Anticancer Applications:
spiroOngoing research continues to explore the depth of therapeutic applications for spiro[benzofuran-3(2H),4'-piperidine], with the anticipation of further uncovering its potential benefits across a spectrum of medical needs.
Check Digit Verification of cas no
The CAS Registry Mumber 171-77-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,7 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 171-77:
(5*1)+(4*7)+(3*1)+(2*7)+(1*7)=57
57 % 10 = 7
So 171-77-7 is a valid CAS Registry Number.
171-77-7Relevant academic research and scientific papers
1, 2, 4-TRIAZOLE DERIVATIVES AND THEIR USE AS OXYTOCIN ANTAGONISTS
-
Page/Page column 46, (2010/11/23)
The present invention relates to a class of substituted triazoles of formula (I), uses thereof, and compositions containing said compounds. These compounds have activity as oxytocin antagonists.
Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues
Chen, Meng-Hsin,Pollard, Patrick P.,Patchett, Arthur A.,Cheng, Kang,Liente, Wei,Chan, Wanda W.-S.,Butler, Bridget,Jacks, Thomas M.,Smith, Roy G.
, p. 1261 - 1266 (2007/10/03)
The synthesis and biological activities of a series of spiroheterocyclic growth hormone secretagogues are reported. Modification of the spiroindane part-structure of the prototypal secretagogue L-162,752 revealed that the spiroindane could be replaced with spirobenzodihydrothiophen derivatives to enhance not only in vitro potency but also oral activity. In this study non- aromatic D-2-amino-4-cyclohexylbutanoic analogs (8a-8d) were also identified to be active secretagogues.
